Skip to content
Open access

Association of endoscopic and CT response with pathological response after preoperative FLOT-based therapy for gastric and gastroesophageal junction cancer: a retrospective cohort study.

Oct 2026 · Frontiers in Oncology · Vol 16, pp. 1960800 · 0 citations · 23 references
Medicine

Abstract

Background Pathological response to preoperative chemotherapy is prognostically relevant in gastric cancer, but reliable estimation before surgery remains challenging. We evaluated the relationship between routine endoscopic and computed tomography (CT) response assessments and major pathological response (MPR) after FLOT-based therapy. Methods In this retrospective, single-center cohort study, 450 institutional records were screened and 47 patients with gastric or gastroesophageal junction cancer who underwent gastrectomy after FLOT-based therapy and had evaluable pre- and post-treatment endoscopy were included; 37 also had comparable paired CT assessments. Endoscopic and CT responses were classified as complete, partial, stable, or progressive. Pathology reports were harmonized into complete, near-complete, partial, and poor/no response, and MPR was defined as complete or near-complete response. Discrimination was assessed by receiver operating characteristic analysis, and paired endoscopy and CT areas under the curve (AUCs) were compared using the DeLong test. The combined endoscopy-plus-CT model was exploratory. Results MPR occurred in 17 of 47 patients (36.2%), including pathological complete response (pCR) in 10 (21.3%). In the full cohort, endoscopy had an AUC of 0.619 (95% CI, 0.466-0.771) for MPR. In the paired cohort, AUCs were 0.561 (95% CI, 0.379-0.743) for endoscopy and 0.675 (95% CI, 0.501-0.848) for CT (difference, 0.114; p=0.35). The combined model yielded an apparent AUC of 0.692 (95% CI, 0.511-0.873). Both patients with endoscopic complete response had pCR, although this category identified only 2 of 10 pCRs. Conclusions Routine endoscopic response showed limited discrimination for MPR. CT had a numerically higher AUC, but the paired comparison was inconclusive, and combining the modalities did not materially improve discrimination. Given the small paired cohort and heterogeneous pathology reporting, these findings are hypothesis-generating. Standardized prospective assessment is required before endoscopic or CT response can be used to estimate pathological response with clinical confidence.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.